Viridian Therapeutics, Inc. VRDN Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s total debt?
- Viridian Therapeutics, Inc. (VRDN) reported total debt of $36.83M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s total debt changed year-over-year?
- Viridian Therapeutics, Inc.'s total debt increased by 59.4% year-over-year, from $23.11M to $36.83M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s total debt?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s total debt has grown at a 226.2% compound annual growth rate (CAGR), from $100K to $36.96M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.